Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. PepGen Inc.

    World Rank (Jan-05-2024)
    18,296
    Market Cap (Jan-05-2024)
    0.186 Billion USD
    World Rank (Jul-30-2023)
    19,669
    Market Cap (Jul-30-2023)
    0.147 Billion USD
    World Rank (Dec-25-2022)
    14,653
    Market Cap (Dec-25-2022)
    0.355 Billion USD
    World Rank (Jan-07-2022)
    18,400
    Headquarters Country
    Company Profile
    PepGen Inc is a clinical stage biotechnology company focused on advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The headquarters is in Massachusetts.
  2. Syros Pharmaceuticals

    World Rank (Jan-05-2024)
    18,319
    Market Cap (Jan-05-2024)
    0.184 Billion USD
    World Rank (Jul-30-2023)
    23,073
    Market Cap (Jul-30-2023)
    0.077 Billion USD
    World Rank (Dec-25-2022)
    23,861
    Market Cap (Dec-25-2022)
    0.065 Billion USD
    World Rank (Jan-07-2022)
    18,422
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    15 Million USD
    Annual Net Income in USD
    -84 Million USD
    Headquarters Country
  3. Harpoon Therapeutics Inc.

    World Rank (Jan-05-2024)
    18,428
    Market Cap (Jan-05-2024)
    0.181 Billion USD
    World Rank (Jul-30-2023)
    27,758
    Market Cap (Jul-30-2023)
    0.030 Billion USD
    World Rank (Dec-25-2022)
    29,163
    Market Cap (Dec-25-2022)
    0.021 Billion USD
    World Rank (Jan-07-2022)
    18,940
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Headquarters Country
    Company Profile

    Harpoon Therapeutics, Inc is a clinical-stage immuno-oncology company designed for targeted penetration and destruction of solid tumors and hematologic malignancies and engineered to bind to human serum albumin for improved therapeutic schedule and patient convenience. The company annual revenue is 17.4 million USD and 171.5 million USD as on 2020. The headquarters is in USA.

    Merck planning to buy Harpoon Therapeutics for 680 million USD and announced in January-2024.

  4. Seres Therapeutics

    World Rank (Jan-05-2024)
    18,439
    Market Cap (Jan-05-2024)
    0.181 Billion USD
    World Rank (Jul-30-2023)
    11,584
    Market Cap (Jul-30-2023)
    0.600 Billion USD
    World Rank (Dec-25-2022)
    10,764
    Market Cap (Dec-25-2022)
    0.653 Billion USD
    World Rank (Jan-07-2022)
    10,779
    Market Cap (Jan-07-2022)
    0.79 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Operating Income in USD
    -246 Million USD
    Annual Net Income in USD
    -250 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Seres Therapeutics is a Late Clinical Stage Biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome. The company annual revenue is 35 million USD and 145 employees as on 2020. The headquarters is in USA.
  5. Theseus Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    18,525
    Market Cap (Jan-05-2024)
    0.178 Billion USD
    World Rank (Jul-30-2023)
    19,702
    Market Cap (Jul-30-2023)
    0.146 Billion USD
    World Rank (Dec-25-2022)
    17,795
    Market Cap (Dec-25-2022)
    0.209 Billion USD
    World Rank (Jan-07-2022)
    15,306
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Headquarters Country
  6. I-MAB

    World Rank (Jan-05-2024)
    18,548
    Market Cap (Jan-05-2024)
    0.177 Billion USD
    World Rank (Jul-30-2023)
    17,107
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,966
    Market Cap (Dec-25-2022)
    0.289 Billion USD
    World Rank (Jan-07-2022)
    4,633
    Market Cap (Jan-07-2022)
    3.18 Billion USD
    Annual Revenue in USD
    13 Million USD
    Annual Net Income in USD
    -339 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    I-Mab is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company annual revenue is 114.5 million USD. The headquarters is in China.
  7. ProQR Therapeutics

    World Rank (Jan-05-2024)
    18,869
    Market Cap (Jan-05-2024)
    0.166 Billion USD
    World Rank (Jul-30-2023)
    20,566
    Market Cap (Jul-30-2023)
    0.123 Billion USD
    World Rank (Dec-25-2022)
    18,166
    Market Cap (Dec-25-2022)
    0.194 Billion USD
    World Rank (Jan-07-2022)
    13,266
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Headquarters Country
  8. Capricor Therapeutics

    World Rank (Jan-05-2024)
    18,961
    Market Cap (Jan-05-2024)
    0.163 Billion USD
    World Rank (Jul-30-2023)
    20,980
    Market Cap (Jul-30-2023)
    0.114 Billion USD
    World Rank (Dec-25-2022)
    22,276
    Market Cap (Dec-25-2022)
    0.089 Billion USD
    World Rank (Jan-07-2022)
    24,681
    Market Cap (Jan-07-2022)
    0.07 Billion USD
    Headquarters Country
  9. G1 Therapeutics

    World Rank (Jan-05-2024)
    19,035
    Market Cap (Jan-05-2024)
    0.161 Billion USD
    World Rank (Jul-30-2023)
    20,661
    Market Cap (Jul-30-2023)
    0.121 Billion USD
    World Rank (Dec-25-2022)
    16,218
    Market Cap (Dec-25-2022)
    0.277 Billion USD
    World Rank (Jan-07-2022)
    14,688
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    45 Million USD
    Annual Net Income in USD
    -99 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in North Carolina, USA.
  10. PDS Biotechnology Corporation

    World Rank (Jan-05-2024)
    19,121
    Market Cap (Jan-05-2024)
    0.159 Billion USD
    World Rank (Jul-30-2023)
    19,008
    Market Cap (Jul-30-2023)
    0.167 Billion USD
    World Rank (Dec-25-2022)
    16,176
    Market Cap (Dec-25-2022)
    0.279 Billion USD
    World Rank (Jan-07-2022)
    18,654
    Market Cap (Jan-07-2022)
    0.21 Billion USD
    Headquarters Country

Share

Ads